• Cyclosporin A: Designing Exposure-Aware Experiments

  2026-09-24

  Cyclosporin A is often studied as an immunosuppressant, but results also depend on where the compound can reach and which cellular readout is measured. This guide connects its biology with practical assay design and a drug-delivery study that illustrates why exposure and mechanism must be separated.

• Arachidonic Acid Workflows for Stroke Research

  2026-09-24

  Use Arachidonic Acid to build controlled, pathway-resolved inflammation assays relevant to cerebral ischemia-reperfusion research. This guide translates a hypothermic albumin perfusion study into practical assay-design ideas—while clearly separating its findings from experiments that directly test arachidonate.

• Poria cocos Polysaccharides and Ferroptosis in ALD

  2026-09-23

  Zhou and colleagues report that Poria cocos polysaccharides improve alcohol-associated liver injury in rat and cell models, alongside changes in NRF2 signaling, oxidative stress, inflammation, and ferroptosis-related measures. The findings support further study of NRF2-linked ferroptosis in alcoholic liver disease, while leaving important questions about mechanism, dosing, and clinical relevance unresolved.

• Molidustat: From HIF Biology to Translational Strategy

  2026-09-23

  Molidustat (BAY85-3934) offers a mechanistically grounded approach to chronic kidney disease anemia by inhibiting HIF prolyl hydroxylases and supporting regulated endogenous erythropoietin production. This thought-leadership perspective connects renal anemia research with emerging HIF-1α, VHL, and Septin4 biology while defining practical boundaries for translational study design.

• Angiotensin II Workflows for Vascular Research

  2026-09-22

  Build reproducible endothelial, vascular remodeling, and chronic infusion models with Angiotensin II while connecting phenotype-level assays to mitochondrial stress and AMPK/Sirt1/Nrf2/ARE signaling. The workflow distinguishes literature-supported conditions from practical optimization choices, helping researchers troubleshoot weak or variable responses.

• Fluorescein TSA Fluorescence System Kit Guide

  2026-09-22

  The Fluorescein TSA Fluorescence System Kit enables high-sensitivity localization of scarce proteins, transcripts, and phosphorylation states in fixed samples. Using BRAF–NMDAR signaling in neuropathic pain as a case study, this guide connects tyramide chemistry with spatial assay design, controls, and interpretation.

• Jiedu Xiaozheng Yin in Colitis-Associated CRC

  2026-09-21

  The reference study shows that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting macrophages toward an M1-like phenotype through TLR4-linked signaling. Its combined animal, histological, transcriptional, and flow-cytometric design provides a useful framework for studying how immune-cell polarization may influence tumor progression, while pharmacologic pathway antagonists offer preliminary mechanistic support rather than definitive target validation.

• Multilineage Organoids Reveal HEV Tissue Tropism

  2026-09-21

  The reference study establishes induced pluripotent stem cell-derived liver, intestinal and brain organoids as physiologically informative models for propagation of clinical HEV genotypes 1, 3 and 4. Its findings extend HEV tropism beyond hepatocytes and provide a multicompartment platform for investigating tissue injury, host responses and antiviral activity.

• Nigericin: Ion Gradients as Translational Levers

  2026-09-20

  Nigericin transforms ion-gradient biology into an experimental strategy. By coupling potassium/hydrogen exchange with intracellular pH modulation, researchers can interrogate mitochondrial stress, cancer-cell survival, GSDMD-associated cellular pyrokinesis, and emerging antibiotic-resistance hypotheses without confusing mechanistic opportunity with clinical evidence.

• CCR5-Containing EVs in Rheumatoid Arthritis

  2026-09-19

  The reference study identifies CCR5-bearing extracellular vesicles released by rheumatoid arthritis synovial fibroblasts as active mediators of cartilage destruction, bone erosion, and NF-κB-associated inflammation. By comparing native, CCR5-deficient, and Maraviroc-loaded vesicles in human cell systems and adjuvant-induced arthritis rats, it provides a mechanistic basis for targeting EV-associated CCR5 rather than treating the receptor only as a soluble-cell-surface target.

• CDCA–FXR–KLF11 Protection in Contrast AKI

  2026-09-18

  A 2026 study identifies an FXR–KLF11 transcriptional pathway through which Chenodeoxycholic Acid (CDCA) reduces contrast-induced acute kidney injury in mouse and HK-2 cell models. The work connects FXR activation to direct KLF11 promoter regulation and downstream suppression of JAK2/STAT3 signaling, inflammation, and apoptosis, while also defining important preclinical limitations.

• One-step TUNEL Cy3 Apoptosis Detection Kit Workflow

  2026-09-18

  Build a reliable DNA fragmentation assay for cultured cells, tissue sections, and translational oncology models with Cy3-based microscopy or flow cytometry. This workflow connects apoptosis readouts to the recent AKT1-targeted colorectal cancer study while emphasizing controls, quantitative analysis, and troubleshooting.

• Nipah Polymerase Structure and Antiviral Implications

  2026-09-17

  The reference study defines the architecture of the Nipah virus L–P polymerase complex and clarifies how polymerase, phosphoprotein, and metal-coordinating domains support viral RNA synthesis and mRNA capping. Its cryo-EM, crystallographic, and modeling results provide a structural framework for antiviral discovery while highlighting which mechanistic hypotheses still require biochemical validation.

• VX-765: Caspase-1 Inhibitor Guide

  2026-09-17

  A scenario-based laboratory guide to using VX-765, Caspase-1 inhibitor, potent and selective (SKU A8238) in viability, cytokine, and pyroptosis assays. It connects practical dosing, solvent handling, controls, and interpretation to published HUVEC findings and product documentation.

• CDCA–FXR–KLF11 Signaling in Contrast-Induced AKI

  2026-09-16

  This study identifies an FXR–KLF11 transcriptional axis through which Chenodeoxycholic Acid suppresses JAK2/STAT3 signaling and reduces contrast-induced acute kidney injury in mouse and HK-2 cell models. Its main contribution is mechanistic: it connects nuclear receptor signaling directly to KLF11 promoter regulation, tubular inflammation, and apoptosis, while providing a rationale for further preclinical prophylaxis research.

8100 records 1/540 page Next 12345 下5页 Last page